Advertisement

Topics

Five Prime’s Williams to Transition from CEO to Executive Chairman

12:30 EDT 23 Jun 2017 | Xconomy

Five Prime Therapeutics (NASDAQ: FPRX) announced that founder Lewis “Rusty” Williams plans to transition from CEO to executive chairman next year. Williams founded South San Francisco, CA-based Five Prime in 2001 and then shifted from CEO to executive chairman in 2003. He returned as CEO in 2011. Five Prime, which is developing drugs to treat […]

Original Article: Five Prime’s Williams to Transition from CEO to Executive Chairman

NEXT ARTICLE

More From BioPortfolio on "Five Prime’s Williams to Transition from CEO to Executive Chairman"

Advertisement
Quick Search
Advertisement
Advertisement